Alkermes plc. Deferred Tax Assets, Gross, Current
Alkermes plc. (ALKS) had Deferred Tax Assets, Gross, Current of $17.51 million as of 2015-09-30, per its 10-Q filed 2015-10-29.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsGrossCurrent · last filed 2016-02-25
- 2015-09-30: Deferred Tax Assets, Gross, Current $17.51M.
- 2015-06-30: Deferred Tax Assets, Gross, Current $15.19M.
- 2015-03-31: Deferred Tax Assets, Gross, Current $14.20M.
- 2014-12-31: Deferred Tax Assets, Gross, Current $13.43M.
| Period end | Deferred Tax Assets, Gross, Current |
|---|---|
| 2015-09-30 | $17.51M 10-Q · filed 2015-10-29 |
| 2015-06-30 | $15.19M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $14.20M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $13.43M 10-K · filed 2016-02-25 |
| 2013-12-31 | $12.78M 10-K · filed 2015-02-24 |
| 2013-03-31 | $5.82M 10-KT · filed 2014-02-27 |
| 2012-03-31 | $656.00K 10-K · filed 2013-05-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |